Uri Kartoun

Dr. Uri Kartoun


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2021 in Circulation
Verified
Journal Article
Closed access
PDF file
APAniruddh P. Patel
Aniruddh P. Patel
MWMinxian Wang
Minxian Wang
UKUri Kartoun
Uri Kartoun
KNKenney Ng
Kenney Ng
AKAmit V. Khera
Amit V. Khera
Background: Individuals of South Asian ancestry represent 23% of the global population, corresponding to 1.8 billion people, and have substantially higher risk of atherosclerotic cardiovascular disease compared with most other ethnicities. US practice guidelines now recognize South Asian ancestry as an important risk-enhancing factor. The magnitude of enhanced risk within the context of contemporary clinical care, the extent to which it is captured by existing risk estimators, and its potential mechanisms warrant additional study. Methods: Within the UK Biobank prospective cohort study, 8124 middle-aged participants of South Asian ancestry and 449 349 participants of European ancestry who were free of atherosclerotic cardiovascular disease at the time of enrollment were examined. The relationship of ancestry to risk of incident atherosclerotic cardiovascular disease—defined as myocardial infarction, coronary revascularization, or ischemic stroke—was assessed with Cox proportional hazards regression, along with examination of a broad range of clinical, anthropometric, and lifestyle mediators. Results: The mean age at study enrollment was 57 years, and 202 405 (44%) were male. Over a median follow-up of 11 years, 554 of 8124 (6.8%) individuals of South Asian ancestry experienced an atherosclerotic cardiovascular disease event compared with 19 756 of 449 349 (4.4%) individuals of European ancestry, corresponding to an adjusted hazard ratio of 2.03 (95% CI, 1.86–2.22; P 2-fold higher observed risk, the predicted 10-year risk of cardiovascular disease according to the American Heart Association/American College of Cardiology Pooled Cohort equations and QRISK3 equations was nearly identical for individuals of South Asian and European ancestry. Adjustment for a broad range of clinical, anthropometric, and lifestyle risk factors led to only modest attenuation of the observed hazard ratio to 1.45 (95% CI, 1.28–1.65, P <0.001). Assessment of variance explained by 18 candidate risk factors suggested greater importance of hypertension, diabetes, and central adiposity in South Asian individuals. Conclusions: Within a large prospective study, South Asian individuals had substantially higher risk of atherosclerotic cardiovascular disease compared with individuals of European ancestry, and this risk was not captured by the Pooled Cohort Equations.

25 October 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
UKUri Kartoun
Uri Kartoun
KCKathleen E. Corey
Kathleen E. Corey
TSTracey G. Simon
Tracey G. Simon
HZHui Zheng
Hui Zheng
RARahul Aggarwal
Rahul Aggarwal
SSStanley Y. Shaw
Stanley Y. Shaw
Accurate assessment of the risk of mortality following a cirrhosis-related admission can enable health-care providers to identify high-risk patients and modify treatment plans to decrease the risk of mortality. We developed a post-discharge mortality prediction model for patients with a cirrhosis-related admission using a population of 314,292 patients who received care either at Massachusetts General Hospital (MGH) or Brigham and Women’s Hospital (BWH) between 1992 and 2010. We extracted 68 variables from the electronic medical records (EMRs), including demographics, laboratory values, diagnosis codes, and medications. We then used a regularized logistic regression to select the most informative variables and created a risk score that comprises the selected variables. To evaluate the potential for generalizability of our score, we applied it on all cirrhosis-related admissions between 2010 and 2015 at an independent EMR data source of more than 18 million patients, pooled from different health-care systems with EMRs. We calculated the areas under the receiver operating characteristic curves (AUROCs) to assess prediction performance. We identified 4,781 cirrhosis-related admissions at MGH/BWH hospitals, of which 778 resulted in death within 90 days of discharge. Nine variables were the most effective predictors for 90-day mortality, and these included all MELD-Na’s components, as well as albumin, total cholesterol, white blood cell count, age, and length of stay. Applying our nine-variable risk score (denoted as “MELD-Plus”) resulted in an improvement over MELD and MELD-Na scores in several prediction models. On the MGH/BWH 90-day model, MELD-Plus improved the performance of MELD-Na by 11.4% (0.78 [95% CI, 0.75–0.81] versus 0.70 [95% CI, 0.66–0.73]). In the MGH/BWH approximate 1-year model, MELD-Plus improved the performance of MELD-Na by 8.3% (0.78 [95% CI, 0.76–0.79] versus 0.72 [95% CI, 0.71–0.73]). Performance improvement was similar when the novel MELD-Plus risk score was applied to an independent database; when considering 24,042 cirrhosis-related admissions, MELD-Plus improved the performance of MELD-Na by 16.9% (0.69 [95% CI, 0.69–0.70] versus 0.59 [95% CI, 0.58–0.60]). We developed a new risk score, MELD-Plus that accurately stratifies the short-term mortality of patients with established cirrhosis, following a hospital admission. Our findings demonstrate that using a small set of easily accessible structured variables can help identify novel predictors of outcomes in cirrhosis patients and improve the performance of widely used traditional risk scores.

9 December 2020 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
SKShaan Khurshid
Shaan Khurshid
UKUri Kartoun
Uri Kartoun
JAJeffrey M. Ashburner
Jeffrey M. Ashburner
LTLudovic Trinquart
Ludovic Trinquart
APAnthony Philippakis
Anthony Philippakis
SLSteven A. Lubitz
Steven A. Lubitz
Background: Atrial fibrillation (AF) is associated with increased risks of stroke and heart failure. Electronic health record (EHR)–based AF risk prediction may facilitate efficient deployment of interventions to diagnose or prevent AF altogether. Methods: We externally validated an electronic health record AF (EHR-AF) score in IBM Explorys Life Sciences, a multi-institutional dataset containing statistically deidentified EHR data for over 21 million individuals (Explorys Dataset). We included individuals with complete AF risk data, ≥2 office visits within 2 years, and no prevalent AF. We compared EHR-AF to existing scores including CHARGE-AF (Cohorts for Heart and Aging Research in Genomic Epidemiology Atrial Fibrillation), C 2 HEST (coronary artery disease or chronic obstructive pulmonary disease, hypertension, elderly, systolic heart failure, thyroid disease), and CHA 2 DS 2 -VASc. We assessed association between AF risk scores and 5-year incident AF, stroke, and heart failure using Cox proportional hazards modeling, 5-year AF discrimination using C indices, and calibration of predicted AF risk to observed AF incidence. Results: Of 21 825 853 individuals in the Explorys Dataset, 4 508 180 comprised the analysis (age 62.5, 56.3% female). AF risk scores were strongly associated with 5-year incident AF (hazard ratio per SD increase 1.85 using CHA 2 DS 2 -VASc to 2.88 using EHR-AF), stroke (1.61 using C 2 HEST to 1.92 using CHARGE-AF), and heart failure (1.91 using CHA 2 DS 2 -VASc to 2.58 using EHR-AF). EHR-AF (C index, 0.808 [95% CI, 0.807–0.809]) demonstrated favorable AF discrimination compared to CHARGE-AF (0.806 [95% CI, 0.805–0.807]), C 2 HEST (0.683 [95% CI, 0.682–0.684]), and CHA 2 DS 2 -VASc (0.720 [95% CI, 0.719–0.722]). Of the scores, EHR-AF demonstrated the best calibration to incident AF (calibration slope, 1.002 [95% CI, 0.997–1.007]). In subgroup analyses, AF discrimination using EHR-AF was lower in individuals with stroke (C index, 0.696 [95% CI, 0.692–0.700]) and heart failure (0.621 [95% CI, 0.617–0.625]). Conclusions: EHR-AF demonstrates predictive accuracy for incident AF using readily ascertained EHR data. AF risk is associated with incident stroke and heart failure. Use of such risk scores may facilitate decision support and population health management efforts focused on minimizing AF-related morbidity.

1 February 2021 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
PDF file
JDJacqueline S. Dron
Jacqueline S. Dron
MWMinxian Wang
Minxian Wang
APAniruddh P. Patel
Aniruddh P. Patel
UKUri Kartoun
Uri Kartoun
KNKenney Ng
Kenney Ng
AKAmit V. Khera
Amit V. Khera

1 November 2019 in Software Impacts
Verified
Journal Article
Open access
UKUri Kartoun
Uri Kartoun

6 September 2019 in Current Medical Research and Opinion
Verified
Journal Article
Open access
UKUri Kartoun
Uri Kartoun
KIKristy Iglay
Kristy Iglay
RSR. Ravi Shankar
R. Ravi Shankar
ABAndrew Beam
Andrew Beam
LRLarry Radican
Larry Radican
SSStanley Shaw
Stanley Shaw
AIMS: To assess demographic and clinical characteristics associated with clinical inertia in a real-world cohort of type 2 diabetes mellitus patients not at hemoglobin A1c goal (<7%) on metformin monotherapy. METHODS: Adult (≥18 years) type 2 diabetes mellitus patients who received care at Massachusetts General Hospital/Brigham and Women’s Hospital and received a new metformin prescription between 1992 and 2010 were included in the analysis. Clinical inertia was defined as two consecutive hemoglobin A1c measures ≥7% ≥3 months apart while remaining on metformin monotherapy (i.e., without add-on therapy). The association between clinical inertia and demographic and clinical characteristics was examined via logistic regression. RESULTS: Of 2,848 eligible patients, 43% did not achieve hemoglobin A1c goal of <7% 3 months after metformin monotherapy initiation. A subgroup of 1,533 patients was included in the clinical inertia analysis, of which 36% experienced clinical inertia. Asian race was associated with an increased likelihood of clinical inertia (Odds ratio, 2.43; 95% Confidence interval, 1.48–3.96), while congestive heart failure had a decreased likelihood (Odds ratio, 0.58; 95% Confidence interval, 0.32–0.98). Chronic kidney disease and cardiovascular/cerebrovascular disease had weaker associations but were directionally similar to congestive heart failure. CONCLUSIONS: Asian patients were at an increased risk of clinical inertia, whereas patients with comorbidities appeared to have their treatment more appropriately intensified. A better understanding of these factors may inform efforts to decrease likelihood for clinical inertia.